z-logo
open-access-imgOpen Access
Multisystemic Severe Form Pseudohypoaldosteronism: Can Gastrostomy be Useful in the Management?
Author(s) -
Aşan Önder,
Semra Çeti̇nkaya,
Cengiz KARA,
Ayşegül Zenciroğlu,
Zehra Aycan
Publication year - 2015
Publication title -
turkish journal of pediatric disease
Language(s) - English
Resource type - Journals
eISSN - 1307-4490
pISSN - 2148-3566
DOI - 10.12956/tjpd.2015.146
Subject(s) - pseudohypoaldosteronism , gastrostomy , medicine , intensive care medicine , hyperkalemia , surgery
A ten-day-old male infant was brought to the hospital with vomiting. On admission, he was hypotonic and had accompanying mild dehydration. The laboratory findings revealed hyponatremia, hyperkalemia, and mild metabolic acidosis. The hormone profile (plasma renin activity: 45 ng/ml/h, aldosterone >20 000 pg/ml, ACTH: 53 pg/ml, 17 OH progesterone: 6.7 ng/ml) revealed pseudohypoaldosteronism (PHA). Oral and IV NaCl, anti-potassium therapy (kayexalate), and low-potassium formula were started. His daily salt requirement was 12 grams. He was not able to take this total salt requirement orally. Respiratory symptoms and diarrhea episodes developed at the age of 3 months. The sodium concentration of sweat was 106 mEq/L. He was therefore diagnosed with multisystemic severe form of type 1 PHA. Severe salt wasting could not be treated. We planned to perform gastrostomy to administer his medications effectively but he died due to a salt-wasting crisis.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom